Trial comparisons

curl "https://conductscience.org/api/comparisons/v1?page=106"

Response

The first 2 of this page's 20 results. GET /api/comparisons/v1?page=106

{
  "data": {
    "total": 85013,
    "results": [
      {
        "id": "NCT00382408-3b51d6a4",
        "title": "Vaccine vs Placebo: Number of Participants With Wild Type-4 Febrile Adenovirus (ADV) Acute Respiratory Disease (ARD) -- ITT Cohort",
        "summary": "1 of 3031 against 48 of 1009; risk difference -4.7 points, 95% interval -6.2 to -3.6; NCT00382408, A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001",
        "record": "/library/comparisons/NCT00382408-3b51d6a4",
        "nct_id": "NCT00382408",
        "kind": "outcome",
        "participants": 4040,
        "risk_difference": {
          "value": -0.04724192920266594,
          "lower": -0.062181147419366437,
          "upper": -0.035634913513861
        },
        "group_1": "1 of 3,031",
        "group_2": "48 of 1,009",
        "difference": "-4.7 points",
        "interval": "-6.2 to -3.6",
        "trial_title": "A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001"
      },
      {
        "id": "NCT00382408-84f8f823",
        "title": "Vaccine vs Placebo: Number of Participants With Wild Type-4 Adenovirus (ADV) Acute Respiratory Disease (ARD) -- ITT Cohort",
        "summary": "3 of 3031 against 65 of 1009; risk difference -6.3 points, 95% interval -8.0 to -5.0; NCT00382408, A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001",
        "record": "/library/comparisons/NCT00382408-84f8f823",
        "nct_id": "NCT00382408",
        "kind": "outcome",
        "participants": 4040,
        "risk_difference": {
          "value": -0.0634304456853021,
          "lower": -0.08030432884663094,
          "upper": -0.04973852432938587
        },
        "group_1": "3 of 3,031",
        "group_2": "65 of 1,009",
        "difference": "-6.3 points",
        "interval": "-8.0 to -5.0",
        "trial_title": "A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001"
      }
    ],
    "no_events": 33758,
    "columns": [
      {
        "key": "title",
        "label": "Comparison"
      },
      {
        "key": "group_1",
        "label": "With the outcome",
        "under": "group_2"
      },
      {
        "key": "difference",
        "label": "Risk difference, 95% interval",
        "under": "interval"
      },
      {
        "key": "participants",
        "label": "Participants"
      },
      {
        "key": "nct_id",
        "label": "Trial",
        "under": "trial_title"
      }
    ],
    "order": "Most participants first",
    "kinds": {
      "all": 85013,
      "outcome": 33568,
      "serious-adverse-events": 31897,
      "deaths": 19548
    }
  },
  "release": "trial-comparisons-2026-03-23-0.1.0",
  "terms": [
    {
      "source": "ClinicalTrials.gov's posted results, through CTTI's AACT",
      "license": "ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "Freely available. Acknowledgement requested"
    },
    {
      "source": "ClinicalTrials.gov",
      "license": "none stated",
      "notice": "ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.",
      "short": "No license stated"
    }
  ],
  "next": "/api/comparisons/v1?page=107",
  "request_id": "flG0cqQusScXW81P"
}